Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2014 1
2015 3
2017 1
2018 1
2019 1
2021 1
2022 1
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era.
Sánchez Suárez MDM, Martín Roldán A, Alarcón-Payer C, Rodríguez-Gil MÁ, Poquet-Jornet JE, Puerta Puerta JM, Jiménez Morales A. Sánchez Suárez MDM, et al. Among authors: alarcon payer c. Pharmaceutics. 2023 Dec 29;16(1):55. doi: 10.3390/pharmaceutics16010055. Pharmaceutics. 2023. PMID: 38258066 Free PMC article. Review.
Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy.
Ríos-Tamayo R, Martín-García A, Alarcón-Payer C, Sánchez-Rodríguez D, de la Guardia AMDVD, García Collado CG, Jiménez Morales A, Jurado Chacón M, Cabeza Barrera J. Ríos-Tamayo R, et al. Among authors: alarcon payer c. Drug Des Devel Ther. 2017 Aug 22;11:2399-2408. doi: 10.2147/DDDT.S115456. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28860711 Free PMC article. Review.
Enhanced NSAIDs Solubility in Drug-Drug Formulations with Ciprofloxacin.
Acebedo-Martínez FJ, Domínguez-Martín A, Alarcón-Payer C, Sevillano-Páez A, Verdugo-Escamilla C, González-Pérez JM, Martínez-Checa F, Choquesillo-Lazarte D. Acebedo-Martínez FJ, et al. Among authors: alarcon payer c. Int J Mol Sci. 2023 Feb 7;24(4):3305. doi: 10.3390/ijms24043305. Int J Mol Sci. 2023. PMID: 36834716 Free PMC article.
Risk factors determining adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia.
Del Rosario García B, Viña Romero MM, González Rosa V, Alarcón Payer C, Oliva Oliva L, Merino Alonso FJ, Nazco Casariego GJ, Gutiérrez Nicolás F. Del Rosario García B, et al. Among authors: alarcon payer c. J Oncol Pharm Pract. 2023 Sep 25:10781552231196130. doi: 10.1177/10781552231196130. Online ahead of print. J Oncol Pharm Pract. 2023. PMID: 37748859
Novel Polymorphic Cocrystals of the Non-Steroidal Anti-Inflammatory Drug Niflumic Acid: Expanding the Pharmaceutical Landscape.
Acebedo-Martínez FJ, Alarcón-Payer C, Frontera A, Barbas R, Prohens R, Di Crisci M, Domínguez-Martín A, Gómez-Morales J, Choquesillo-Lazarte D. Acebedo-Martínez FJ, et al. Among authors: alarcon payer c. Pharmaceutics. 2021 Dec 13;13(12):2140. doi: 10.3390/pharmaceutics13122140. Pharmaceutics. 2021. PMID: 34959421 Free PMC article.
14 results